Primary Aldosteronism Due to Nodular Hyperplasia
1 clinical trials · Condition
◉ Watch Primary Aldosteronism Due to Nodular Hyperplasia
| Record | Firm | Date |
|---|---|---|
| First-in-human Evaluation of [18F]CETO (NCT05361083) | Uppsala University | 2019-09-01 |
Track Primary Aldosteronism Due to Nodular Hyperplasia automatically
Every clearance here is in the API, with alerts when new ones post.